A detailed history of Bessemer Group Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 50 shares of FLGT stock, worth $893. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Holding current value
$893
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$19.6 - $25.06 $980 - $1,253
50 New
50 $1,000
Q3 2023

Nov 13, 2023

SELL
$26.74 - $40.81 $828 - $1,265
-31 Reduced 43.66%
40 $1,000
Q2 2023

Aug 10, 2023

BUY
$28.52 - $40.7 $884 - $1,261
31 Added 77.5%
71 $2,000
Q4 2021

Jan 27, 2022

BUY
$77.3 - $105.0 $3,092 - $4,200
40 New
40 $4,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $541M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.